InsidersTradesSigma
Follow the Avadel Pharmaceuticals PLC stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Avadel Pharmaceuticals PLC has logged 56 reports. The latest transaction was filed on 18 February 2026 (Cession). Among the most active insiders: Palczuk Linda. All data is accessible without an account.
56
Insider Decl.
n/a
Thresholds
€2m
27 ops.
Buy Volume
€212m
12 ops.
Sell Volume
48Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 February 2026
Declarations56 total
11,112,052 shares@ US$21.00100.0% of flowOrdinary SharesSEC:0001357550-26-000015:0
115,060 shares@ US$21.0092.8% of flowOrdinary SharesSEC:0001104659-26-014448:0
23,496 shares@ US$21.00100.0% of flowOrdinary SharesSEC:0001104659-26-014447:0
78,905 shares@ US$21.0091.5% of flowOrdinary SharesSEC:0001104659-26-014446:0
100,400 shares@ US$21.0087.1% of flowOrdinary SharesSEC:0001104659-26-014445:0
22,000 shares@ US$21.0022.1% of flowOrdinary SharesSEC:0001104659-26-014444:0
22,005 shares@ US$21.0041.9% of flowOrdinary SharesSEC:0001104659-26-014443:0
219,905 shares@ US$21.0086.4% of flowOrdinary SharesSEC:0001104659-26-014442:0
211,105 shares@ US$21.0092.3% of flowOrdinary SharesSEC:0001104659-26-014441:0
22,000 shares@ US$21.00100.0% of flowOrdinary SharesSEC:0001104659-26-014438:0
67,025 shares0Ordinary SharesSEC:0001104659-26-011511:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072695:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072692:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072687:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072686:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072685:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072682:0
52,000 shares0Ordinary SharesSEC:0001104659-25-021732:0
14,700 shares0Ordinary SharesSEC:0001104659-25-021736:0
12,600 shares0Ordinary SharesSEC:0001104659-25-021733:0
5,000 shares@ US$7.92829.5% of flowOrdinary SharesSEC:0001104659-25-005248:0
Canonical exit: 21 Apr 2025 (T+90)
10,000 shares@ US$8.04549.9% of flowOrdinary SharesSEC:0001104659-25-003452:0
Canonical exit: 13 Apr 2025 (T+90)
30,000 shares@ US$7.840637.4% of flowOrdinary SharesSEC:0001104659-25-003451:0
Canonical exit: 13 Apr 2025 (T+90)
3,500 shares0Ordinary SharesSEC:0001104659-24-132145:0
2,300 shares@ US$10.44298.7% of flowOrdinary SharesSEC:0001104659-24-128666:0
Canonical exit: 13 Mar 2025 (T+90)
25 of 56 declarations
Acerca de Avadel Pharmaceuticals PLC
Avadel Pharmaceuticals PLC es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para trastornos del sueño y otras enfermedades. Cotiza en el NASDAQ bajo el ticker AVDL.